Cell-Based Immunotherapies

New for 2020, The Cell-Based Immunotherapy stream focuses on the latest protein engineering, clinical and analytical strategies driving the development of cell-based immunotherapies such as CAR Ts, TCRs, TILs and NKs, for the treatment of cancer and immune disorders. Topics include improving target identification, optimizing product design, specificity, safety, characterization and analytics.

Conferences Include:

May 4 - 5

Improving Immunotherapy Efficacy and Safety

May 6 - 7

CAR Ts, TCRs and TILs

May 7 - 8

Cell and Gene Therapy Analytics


Keynote Speakers:

 

Prasad Adusumilli, MD, FACS, FCCP Deputy Chief and Associate Attending, Thoracic Surgery; Director, Mesothelioma


Adrian Bot, PhD Vice President, Translational Medicine, Kite Pharma, a Gilead Company


Jan Joseph (Jos) Melenhorst, PhD Adjunct Associate Professor, Pathology & Laboratory Medicine, University of Pennsylvania


Jeffrey Miller, MD Professor of Medicine, Deputy Director, Masonic Cancer Center, Division of Hematology, Oncology and Transplantation, University of Minnesota

Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean


Update History
2020/03/04
Agenda,Sponsor updated
2020/02/13
Agenda,Speaker,Sponsor updated
2020/01/08
Agenda,Sponsor updated
2019/12/09
Event Information updated
2019/11/25
Sponsor updated



View By: